|

REGistry of Long-term AnTithrombotic TherApy-1

RECRUITINGSponsored by National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Actively Recruiting
SponsorNational Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Started2015-01-15
Est. completion2026-01-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04347200

Summary

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* coronary artery disease , confirmed by history of myocardial infarction, or revascularization, or definitive evidence of CAD on imaging

Exclusion Criteria:

* Subjects who are unwilling or unable to provide informed consent.
* Acute coronary syndrome within 12 months before inclusion
* Severe chronic heart failure (NYHA IV)
* Stroke within 6 months before inclusion
* Severe liver or muscle disease
* Severe kidney disease / renal failure with creatinine \> 3 mg/dl
* Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention -

Conditions3

Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))Heart DiseasePeripheral Artery Disease

Interventions1

Antiplatelet Drug

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.